Respiratory, cardiovascular and other physiological consequences of smoking cessation

Current Medical Research and Opinion

Volumn 25, Issue 2, 2009, Pages 535-545

  Gratziou, Christina ^a,b,c  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b Asthma and Allergy Centre   (Greece)

^c Evgenidion Hospital   (Greece)

Author keywords

Cardiovascular disease; CYP1A2 activity; Pulmonary disease; Smoking cessation

Indexed keywords

CYTOCHROME P450 1A2;

CARDIOVASCULAR RISK; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONSTIPATION; DISEASE SEVERITY; DRUG METABOLISM; ENDOTHELIAL DYSFUNCTION; ENZYME ACTIVITY; HUMAN; HYPERTENSION; INFORMATION RETRIEVAL; LUNG FUNCTION; MEDLINE; MORBIDITY; MORTALITY; MOTIVATION; MOUTH ULCER; PATHOPHYSIOLOGY; PATIENT EDUCATION; RESPIRATORY TRACT DISEASE; RESPIRATORY TRACT INFLAMMATION; REVIEW; RISK REDUCTION; SMOKING CESSATION; SYSTEMATIC REVIEW; WEIGHT GAIN; WITHDRAWAL SYNDROME; ARTICLE; BREATHING; CARDIOVASCULAR SYSTEM;

CARDIOVASCULAR SYSTEM; HUMANS; RESPIRATION; SMOKING CESSATION;

EID: 64249118494     PISSN: 03007995     EISSN: 14734877     Source Type: Journal    
DOI: 10.1185/03007990802707642     Document Type: Review

References (74)

1. Doll R, Peto R, Boreham J, et al. Mortality in relation to smoking: 50 years' observations on male British doctors. BMJ 2004;328:1519 (Pubitemid 38850305)
2. Berlin I. Endocrine and metabolic effects of smoking cessation. Cur Med Res Opin 2009; 25: (this supplement)
3. Anthonisen NR, Connett JE, Kiley JP, et al. Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study. JAMA 1994;272:1497-1505 (Pubitemid 24986688)
4. Anthonisen NR, Connett JE, Murray RP. Smoking and lung function of Lung Health Study participants after 11 years. Am J Respir Crit Care Med 2002;166:675-679 (Pubitemid 34971849)
5. Fletcher C, Peto R. The natural history of chronic airflow obstruction. Br Med J 1977;1:1645-1648 (Pubitemid 8124466)
6. Scanlon PD, Connett JE, Waller LA, et al. Smoking cessation and lung function in mild-to-moderate chronic obstructive pulmonary disease. The Lung Health Study. American Journal of Respiratory and Critical Care Medicine 2000; 161:381-390 (Pubitemid 30129442)
7. Tønnesen P, Pisinger C, Hvidberg S, et al. Effects of smoking cessation and reduction in asthmatics. Nicotine Tob Res 2005; 7:139-148 (Pubitemid 40613171)
8. Van Overveld FJ, Demkow U, Górecka D, et al. Differences in responses upon corticosteroid therapy between smoking and non-smoking patients with COPD. J Physiol Pharmacol 2006;57(Suppl 4):273-282 (Pubitemid 44638210)
9. Wise RA, Kanner RE, Lindgren P, et al. The effect of smoking intervention and an inhaled bronchodilator on airways reactivity in COPD: the Lung Health Study. Chest 2003;124:449-458 (Pubitemid 37000119)
10. Rabe KF, Hurd S, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. American Journal of Respiratory and Critical Care Medicine 2007; 176:532-555 (Pubitemid 47403272)
11. Oren S, Isakov I, Golzman B, et al. The influence of smoking cessation on hemodynamics and arterial compliance. Angiology 2006;57:564-568 (Pubitemid 44564311)
12. Eagan TM, Gulsvik A, Eide GE, et al. Remission of respiratory symptoms by smoking and occupational exposure in a cohort study. Eur Respir J 2004;23:589-594 (Pubitemid 38456002)
13. Stein MD, Weinstock MC, Herman DS, et al. Respiratory symptom relief related to reduction in cigarette use. J Gen Intern Med 2005;20:889-894 (Pubitemid 41726671)
14. Hatsukami DK, Kotlyar M, Allen S, et al. Effects of cigarette reduction on cardiovascular risk factors and subjective measures. Chest 2005;128:2528-2537 (Pubitemid 41507604)
15. Haustein KO, Krause J, Haustein H, et al. Changes in hemorheological and biochemical parameters following short-term and long-term smoking cessation induced by nicotine replacement therapy (NRT). Int J Clin Pharmacol Ther 2004;42:83-92 (Pubitemid 38219919)
16. Hosokawa S, Hiasa Y, Miyazaki S, et al. Effects of smoking cessation on coronary endothelial function in patients with recent myocardial infarction. Int J Cardiol 2008;128:48-52 (Pubitemid 351905759)
17. Twardella D, Kü pper-Nybelen J, Rothenbacher D, et al. Short-term benefit of smoking cessation in patients with coronary heart disease: estimates based on self-reported smoking data and serum cotinine measurements. Eur Heart J 2004;25:2101-2108
18. Willemse BW, ten Hacken NH, Rutgers B, et al. Effect of 1-year smoking cessation on airway inflammation in COPD and asymptomatic smokers. Eur Respir J 2005;26:835-845
19. Lapperre TS, Sont JK, van Schadewijk A, et al. Smoking cessation and bronchial epithelial remodelling in COPD: a crosssectional study. Respir Res 2007;8:85
20. Downs SH, Brändli O, Zellweger JP, et al. Accelerated decline in lung function in smoking women with airway obstruction: SAPALDIA 2 cohort study. Respir Res 2005;6:45 (Pubitemid 41358025)
21. Critchley J, Capewell S. Smoking cessation for the secondary prevention of coronary heart disease. Cochrane Database Syst Rev 2004;(1):CD003041
22. Dagenais GR, Yi Q, Lonn E, et al. Impact of cigarette smoking in high-risk patients participating in a clinical trial. A substudy from the Heart Outcomes Prevention Evaluation (HOPE) trial. Eur J Cardiovasc Prev Rehabil 2005;12:75-81 (Pubitemid 40388297)
23. Woodward M, Lam TH, Barzi F, et al. Smoking, quitting, and the risk of cardiovascular disease among women and men in the Asia-Pacific region. Int J Epidemiol 2005;34:1036-1045 (Pubitemid 41541738)
24. Wannamethee SG, Lowe GD, Shaper AG, et al. Associations between cigarette smoking, pipe/cigar smoking, and smoking cessation, and haemostatic and inflammatory markers for cardiovascular disease. Eur Heart J 2005;26:1765-1773 (Pubitemid 41219850)
25. Viegi G, Sherrill DL, Carrozzi L, et al. An 8-year follow-up of carbon monoxide diffusing capacity in a general population sample of northern Italy. Chest 2001;120:74-80 (Pubitemid 32744860)
26. Cui R, Iso H, Yamagishi K, et al. Relationship of smoking and smoking cessation with ankle-to-arm blood pressure index in elderly Japanese men. Eur J Cardiovasc Prev Rehabil 2006; 13:243-248 (Pubitemid 44097730)
27. Connett JE, Murray RP, Buist AS, et al. Changes in smoking status affect women more than men: results of the Lung Health Study. Am J Epidemiol 2003;157:973-979 (Pubitemid 36628800)
28. Sherrill DL, Holberg CJ, Enright PL, et al. Longitudinal analysis of the effects of smoking onset and cessation on pulmonary function. Am J Respir Crit Care Med 1994;149:591-597 (Pubitemid 24082211)
29. Bolliger CT, Zellweger JP, Danielsson T, et al. Influence of longterm smoking reduction on health risk markers and quality of life. Nicotine Tob Res 2002;4:433-439 (Pubitemid 35469977)
30. Chinn S, Jarvis D, Melotti R, et al. Smoking cessation, lung function, and weight gain: a follow-up study. Lancet 2005; 365:1629-1635 (Pubitemid 40693412)
31. Willemse BW, Postma DS, Timens W, et al. The impact of smoking cessation on respiratory symptoms, lung function, airway hyperresponsiveness and inflammation. Eur Respir J 2004;23:464-476 (Pubitemid 38344387)
32. Baumgartner KB, Samet JM, Stidley CA, et al. Cigarette smoking: a risk factor for idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1997;155:242-248 (Pubitemid 27053171)
33. Fennerty AG, Banks J, Ebden P, et al. The effect of cigarette withdrawal on asthmatics who smoke. Eur J Respir Dis 1987; 71:395-399 (Pubitemid 18018874)
34. Chaudhuri R, Livingston E, McMahon AD, et al. Effects of smoking cessation on lung function and airway inflammation in smokers with asthma. Am J Respir Crit Care Med 2006;174:127-133 (Pubitemid 44015385)
35. Suzuki K, Tanaka H, Kaneko S, et al. Respiratory symptoms and cigarette smoking in 3,197 pulmonologist-based asthmatic patients with a highly prevalent use of inhaled corticosteroid. J Asthma 2003;40:243-250 (Pubitemid 36676403)
36. Chaudhuri R, Livingston E, McMahon AD, et al. Cigarette smoking impairs the therapeutic response to oral corticosteroids in chronic asthma. Am J Respir Crit Care Med 2003;168:1308-1311 (Pubitemid 37487324)
37. Wanner A, Campos MA, Mendes E. Airway blood flow reactivity in smokers. Pulm Pharmacol Ther 2007;20:126-129 (Pubitemid 44780152)
38. Lapperre TS, Postma DS, Gosman MM, et al. Relation between duration of smoking cessation and bronchial inflammation in COPD. Thorax 2006;61:115-121 (Pubitemid 43235427)
39. Mohiuddin SM, Mooss AN, Hunter CB, et al. Intensive smoking cessation intervention reduces mortality in high-risk smokers with cardiovascular disease. Chest 2007;131:446-452 (Pubitemid 46280405)
40. Eliasson B, Hjalmarson A, Kruse E, et al. Effect of smoking reduction and cessation on cardiovascular risk factors. Nicotine Tob Res 2001;3:249-255 (Pubitemid 32821652)
41. Tønnesen P, Carrozzi L, Fagerström KO, et al. Smoking cessation in patients with respiratory diseases: a high priority, integral component of therapy. Eur Respir J 2007;29:390-417 (Pubitemid 46231920)
42. Botella-Carretero JI, Escobar-Morreale HF, Martin I, et al. Weight gain and cardiovascular risk factors during smoking cessation with bupropion or nicotine. Horm Metab Res 2004; 36:178-182 (Pubitemid 38510040)
43. Lee DH, Ha MH, Kim JR, et al. Effects of smoking cessation on changes in blood pressure and incidence of hypertension: a 4-year follow-up study. Hypertension 2001;37:194-198 (Pubitemid 32199073)
44. Janzon E, Hedblad B, Berglund G, et al. Changes in blood pressure and body weight following smoking cessation in women. J Intern Med 2004;255:266-272 (Pubitemid 38241371)
45. Diverse Populations Collaboration. Smoking, body weight, and CHD mortality in diverse populations. Preventive Medicine 2004;38:834-840 (Pubitemid 38757535)
46. Bartholomew HC, Knuiman MW. Longitudinal analysis of the effect of smoking cessation on cardiovascular risk factors in a community sample: the Busselton Study. J Cardiovasc Risk 1998;5:263-271 (Pubitemid 29030113)
47. Buchanan L, Likness S. Evidence-based practice to assist women in hospital settings to quit smoking and reduce cardiovascular disease risk. J Cardiovasc Nurs 2008;23:397-406
48. Prochaska JJ, Hall SM, Humfleet G, et al. Physical activity as a strategy for maintaining tobacco abstinence: a randomized trial. Prev Med 2008;47:215-220
49. Nilsson P, Lundgren H, Sö derström M, et al. Effects of smoking cessation on insulin and cardiovascular risk factors - a controlled study of 4 months' duration. J Intern Med 1996;240:189-194 (Pubitemid 26356040)
50. Jatoi NA, Jerrard-Dunne P, Feely J, et al. Impact of smoking and smoking cessation on arterial stiffness and aortic wave reflection in hypertension. Hypertension 2007;49:981-985 (Pubitemid 351664328)
51. Stratelis G, Jakobsson P, Molstad S, et al. Early detection of COPD in primary care: screening by invitation of smokers aged 40 to 55 years. Br J Gen Pract 2004;54:201-206 (Pubitemid 38292015)
52. Warner DO, Colligan RC, Hurt RD, et al. Cough following initiation of smoking abstinence. Nicotine Tob Res 2007; 9:1207-1212 (Pubitemid 350066239)
53. Ussher M, West R, Evans P, et al. Acute reduction in secretory immunoglobulin A following smoking cessation. Psychoneuroendocrinology 2004;29:1335-1340 (Pubitemid 39024359)
54. Farr BM, Bartlett CL, Wadsworth J, et al. Risk factors for community- acquired pneumonia diagnosed upon hospital admission. British Thoracic Society Pneumonia Study Group. Respir Med 2000;94:954-963 (Pubitemid 30806722)
55. Arcavi L, Benowitz NL. Cigarette smoking and infection. Arch Intern Med 2004;164:2206-2216 (Pubitemid 39452980)
56. Gajalakshmi V, Peto R, Kanaka TS, et al. Smoking and mortality from tuberculosis and other diseases in India: retrospective study of 43000 adult male deaths and 35000 controls. Lancet 2003;362:507-515 (Pubitemid 36976714)
57. Nuorti JP, Butler JC, Farley MM, et al. Cigarette smoking and invasive pneumococcal disease. Active Bacterial Core Surveillance Team. N Engl J Med 2000;342:681-689
58. Can G, Oztuna F, Topbaş M. Complaints related to smoking cessation. Tuberk Toraks 2007;55:364-369 (Pubitemid 350225544)
59. Aveyard P, Johnson C, Fillingham S, et al. Nortriptyline plus nicotine replacement versus placebo plus nicotine replacement for smoking cessation: pragmatic randomised controlled trial. BMJ 2008;336:1223-1227 (Pubitemid 351809316)
60. Hajek P, Gillison F, McRobbie H. Stopping smoking can cause constipation. Addiction 2003;98:1563-1567 (Pubitemid 37373854)
61. Aubin HJ, Bobak A, Britton JR, et al. Varenicline versus transdermal nicotine patch for smoking cessation: results from a randomised open-label trial. Thorax 2008;63:717-724
62. Nides M, Glover ED, Reus VI, et al. Varenicline versus bupropion SR or placebo for smoking cessation: a pooled analysis. Am J Health Behav 2008;32:664-675
63. McRobbie H, Hajek P, Gillison F. The relationship between smoking cessation and mouth ulcers. Nicotine Tob Res 2004;6:655-659 (Pubitemid 39248152)
64. Cummings KM, Giovino G, Jaén CR, et al. Reports of smoking withdrawal symptoms over a 21 day period of abstinence. Addict Behav 1985;10:373-381 (Pubitemid 16174447)
65. Chung WG, Kang JH, Park CS, et al. Effect of age and smoking on in vivo CYP1A2, flavin-containing monooxygenase, and xanthine oxidase activities in Koreans: determination by caffeine metabolism. Clin Pharmacol Ther 2000;67:258-266 (Pubitemid 30176384)
66. Bozikas VP, Papakosta M, Niopas I, et al. Smoking impact on CYP1A2 activity in a group of patients with schizophrenia. Eur Neuropsychopharmacol 2004;14:39-44 (Pubitemid 37495029)
67. Wishart DS, Knox C, Guo AC, et al. DrugBank: a comprehensive resource for in silico drug discovery and exploration. Nucleic Acids Res 2006;34:D668-72
68. van der Weide J, Steijns LS, van Weelden MJ. The effect of smoking and cytochrome P450 CYP1A2 genetic polymorphism on clozapine clearance and dose requirement. Pharmacogenetics 2003;13:169-172 (Pubitemid 36324246)
69. Backman JT, Schröder MT, Neuvonen PJ. Effects of gender and moderate smoking on the pharmacokinetics and effects of the CYP1A2 substrate tizanidine. Eur J Clin Pharmacol 2008;64:17-24
70. Zyban® prescribing information. GlaxoSmithKline. 2007. Available at: http://us.gsk.com/products/assets/us-zyban.pdf [Last accessed 24 October 2008]
71. Rigotti NA, Thorndike AN, Regan S, et al. Bupropion for smokers hospitalized with acute cardiovascular disease. Am J Med 2006;119:1080-1087 (Pubitemid 44834365)
72. Nicorette 10mg patch. McNeil Products Ltd. 2008. Available at: http://emc.medicines.org.uk/emc/assets/c/html/displaydoc.asp? documentid=20675 [Last accessed 24 October 2008]
73. Smoking cessation in subjects with mild-to-moderate chronic obstructive pulmonary disease (COPD). Pfizer Inc. 2008. Available at: http://clinicaltrials. gov/ct2/show/NCT00285012 [Last accessed 24 October 2008]
74. Effectiveness and safety of varenicline in smokers with cardiovascular disease who wish to quit smoking. Pfizer Inc. 2008. Available at: http://clinicaltrials.gov/ct2/show/NCT00282984 [Last accessed 24 October 2008]